• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the Corrona Psoriasis Registry.

作者信息

Enos Clinton W, O'Connell Katie A, Harrison Ryan W, McLean Robert R, Dude Blessing, Van Voorhees Abby S

出版信息

J Drugs Dermatol. 2020 Nov 1;19(11):1119-1122. doi: 10.36849/JDD.2020.5366.

DOI:10.36849/JDD.2020.5366
PMID:33196741
Abstract
摘要

相似文献

1
Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the Corrona Psoriasis Registry.生物治疗与疾病特征的地理差异：Corrona银屑病注册研究中的一项初步研究
J Drugs Dermatol. 2020 Nov 1;19(11):1119-1122. doi: 10.36849/JDD.2020.5366.
2
Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry.银屑病全身治疗的联合应用：来自Corrona银屑病登记处的基线特征
J Drugs Dermatol. 2019 Aug 1;18(8):731-740.
3
Proposal for long-term protocols after Psoriasis Area and Severity Index clear with initial biologic therapy: Happily ever after with or without biologics in psoriasis therapy.银屑病面积和严重程度指数经初始生物治疗清除后的长期方案建议：银屑病治疗中使用或不使用生物制剂的幸福结局。
J Dermatol. 2017 Oct;44(10):e234-e235. doi: 10.1111/1346-8138.13930. Epub 2017 Jun 17.
4
Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry.一项基于美国大型队列的疾病负担、合并症和治疗使用情况的特征分析：Corrona 银屑病登记处的研究结果。
J Am Acad Dermatol. 2018 Feb;78(2):323-332. doi: 10.1016/j.jaad.2017.10.012. Epub 2017 Oct 16.
5
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time.中重度银屑病全身治疗的阶梯仅向上发展吗？使用生物制剂治疗重度银屑病的患者比例随时间增加。
Actas Dermosifiliogr. 2015 Oct;106(8):638-43. doi: 10.1016/j.ad.2015.04.013. Epub 2015 Jun 30.
6
Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis.带状疱疹在接受系统性治疗的银屑病大队列患者中的发生率。
JAMA Dermatol. 2018 Feb 1;154(2):218-219. doi: 10.1001/jamadermatol.2017.4840.
7
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.纳入捷克国家登记处BIOREP的银屑病患者的特征和风险概况以及与其他登记处的比较。
Int J Dermatol. 2017 Apr;56(4):428-434. doi: 10.1111/ijd.13543. Epub 2017 Feb 9.
8
Improvement in body surface area is associated with better quality of life among patients with psoriasis in the Corrona Psoriasis Registry.在科罗娜银屑病登记处的银屑病患者中，体表面积的改善与生活质量的提高相关。
J Am Acad Dermatol. 2021 Jun;84(6):1715-1717. doi: 10.1016/j.jaad.2020.08.039. Epub 2020 Aug 13.
9
Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed.在先前的抗白细胞介素17A疗法失败的患者中，使用布罗达单抗治疗中度至重度银屑病。
J Am Acad Dermatol. 2019 Sep;81(3):857-859. doi: 10.1016/j.jaad.2019.05.007. Epub 2019 May 10.
10
The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.减肥对接受生物治疗的肥胖银屑病患者治疗结局的影响：一项随机对照前瞻性试验。
Expert Opin Biol Ther. 2014 Jun;14(6):749-56. doi: 10.1517/14712598.2014.900541. Epub 2014 Mar 24.

引用本文的文献

1
Comorbidities among adult patients with psoriasis in Tianjin: a cross-sectional analysis of the Health Database study.天津成年银屑病患者的合并症：健康数据库研究的横断面分析。
BMJ Open. 2024 May 21;14(5):e083683. doi: 10.1136/bmjopen-2023-083683.
2
Association between retinol binding protein-4 and psoriasis vulgaris: a systematic review and meta-analysis.视黄醇结合蛋白-4与寻常型银屑病之间的关联：一项系统评价和荟萃分析。
Front Med (Lausanne). 2023 Aug 30;10:1208969. doi: 10.3389/fmed.2023.1208969. eCollection 2023.
3
Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States.
美国不同地理区域的银屑病严重程度、合并症及治疗反应存在差异。
JID Innov. 2021 May 6;1(2):100025. doi: 10.1016/j.xjidi.2021.100025. eCollection 2021 Jun.